UBS’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History
Bought
Maintained
Sold
Other funds holding RNA
NMC
A
DM
VLKIM
PCM
SFM
UBS's RNA Position: Q3 2014 in Review
UBS increased its PROSENSA HLDGS N V ORD SHS (NLD) (RNA) stake by 319% in Q3 2014, buying an estimated $31.4K and bringing the position to 4,353 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #7210.
UBS first reported a position in RNA in Q3 2013 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold RNA as of Q3 2014.
- UBS held 4,353 shares of PROSENSA HLDGS N V ORD SHS (NLD) worth $37K as of Q3 2014.
- UBS bought 3,315 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q3 2014, an estimated $31.4K.
- PROSENSA HLDGS N V ORD SHS (NLD) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7210 holding.
- UBS first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and has held it in 4 quarters since.
- 32 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.